Clinical Observation of Distal Protection Device During Primary Angioplasty in Acute Myocardial Infarction

YAO Ying-jie,WANG Xu,SHAO Yi-bin,WANG Zheng-zhong,WANG Yan,YANG Yan-min,ZHANG Cun-quan

DOI: https://doi.org/10.3969/j.issn.1673-6273.2007.02.025

2007-01-01

Abstract:Objective To evaluate the safety and efficacy of distal protection device(GuardWire PlusTM) during high risk PCI in patients with acute myocardial infarction(AMI).Methods Seventy-two patients with AMI admitted from September 2004 to May 2006 who received PCI were categotized into the GuardWire PlusTM group(GW group,n=38) and the conventional guidewire group(NGW group,n=34) according to the device used.The basic clinical characteristics,angiographic results,degree ST of resolution and changes in serum CK-MB and cTnI levels were compared.LVEF was measured by echocardiography at discharge and again at 3 months after PCI.Results All the distal protection deveices were applied successfully in the GW group.A greater percentage of patients in the GW group had post procedural ST-segment resolution ≥50% compared with the NGW group(68.4% vs 41.2%,P0.05).The serum CK-MB reached its peak level at 8.63±2.42 h after onset in the GW group,and at 11.18±2.26 h after onset in the NGW group.The serum peak level of CK-MB was significantly lower in the GW group than that in the NGW group(63.3±9.82 ng/mL vs 74.28±6.15 ng/mL,P=0.000).The peak serum level of cTnI appeared at 10.16±2.96 h after onset in the GW group and at 12.35±2.06 h after onset in the NGW group.The serum peak level of cTnI was also significantly lower in the GW group than that in the NGW group(18.01±7.21 ng/mL vs 21.48±5.61 ng/mL,P=0.027).The left ventricular ejection fraction 3 months after discharge was higher in the GW group than that in the NGW group(57.82%±2.50% vs 55.09%±3.32%,P0.001).Conclusion It is feasible and safe to apply the GuardWire PlusTM distal protection device during PCI in AMI patients to prevent distal embolization,minimize the infarction size and increase LVEF.